Skip to main content
TipRanks
Go Ultimate75% OFF

CARILEX MEDICAL INC. (7726) Financial Statements

CARILEX MEDICAL INC. Financial Overview

CARILEX MEDICAL INC.'s market cap is currently NT$652.77M. The company's EPS TTM is NT$-0.61; its P/E ratio is -52.70; and it has a dividend yield of 1.84%. CARILEX MEDICAL INC. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 338.63MNT$ 351.72MNT$ 466.36MNT$ 335.31MNT$ 387.75M
Gross ProfitNT$ 99.11MNT$ 150.45MNT$ 196.74MNT$ 142.63MNT$ 168.60M
Operating IncomeNT$ -42.76MNT$ 3.03MNT$ 55.38MNT$ 17.57MNT$ 52.25M
EBITDANT$ -5.43MNT$ 42.73MNT$ 78.84MNT$ 56.16MNT$ 59.56M
Net IncomeNT$ -28.98MNT$ 13.48MNT$ 44.44MNT$ 28.86MNT$ 32.34M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 224.27MNT$ 137.10MNT$ 173.16MNT$ 129.41MNT$ 138.94M
Total AssetsNT$ 533.96MNT$ 459.63MNT$ 543.44MNT$ 414.73MNT$ 416.61M
Total DebtNT$ 172.14MNT$ 71.87MNT$ 72.41MNT$ 102.22MNT$ 98.87M
Net DebtNT$ -52.13MNT$ -65.23MNT$ -100.75MNT$ -27.19MNT$ -40.06M
Total LiabilitiesNT$ 243.02MNT$ 129.59MNT$ 191.97MNT$ 177.55MNT$ 213.05M
Stockholders' EquityNT$ 290.93MNT$ 330.04MNT$ 351.48MNT$ 237.18MNT$ 203.56M
Cash Flow
Free Cash FlowNT$ 36.04MNT$ 22.05MNT$ -4.70MNT$ 4.86MNT$ 77.24M
Operating Cash FlowNT$ 46.57MNT$ 24.97MNT$ 1.96MNT$ 33.21MNT$ 78.81M
Investing Cash FlowNT$ -8.34MNT$ -4.85MNT$ -3.52MNT$ -27.38MNT$ -4.28M
Financing Cash FlowNT$ 46.18MNT$ -52.69MNT$ 47.50MNT$ -14.56MNT$ -42.02M

Currency in TWD

CARILEX MEDICAL INC. Earnings and Revenue History

-250M0250M500M-10 %0 %10 %20 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin

CARILEX MEDICAL INC. Liabilities to Assets

0200M400M600M24 %36 %48 %60 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets

CARILEX MEDICAL INC. Cash Flow

-75M-50M-25M025M50M75M100M202020212022202320242025OperatingInvestingFinancing

CARILEX MEDICAL INC. Forecast EPS vs Actual EPS